about
Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccinesA region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodiesIsolation and functional characterization of two distinct sexual-stage-specific promoters of the human malaria parasite Plasmodium falciparumPotent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric NanoparticlesGenetic diversity of Plasmodium vivax and Plasmodium falciparum in Honduras.Murine model for assessment of Plasmodium falciparum transmission-blocking vaccine using transgenic Plasmodium berghei parasites expressing the target antigen Pfs25.Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax.Naturally acquired immunity to sexual stage P. falciparum parasites.Determinants of Malaria Transmission at the Population Level.Impact of the Charge Ratio on the In Vivo Immunogenicity of Lipoplexes.The biology of malarial parasite in the mosquito--a review.Characterization of the modes of action of anti-Pbs21 malaria transmission-blocking immunity: ookinete to oocyst differentiation in vivo.The effect of transmission-blocking antibody ingested in primary and secondary bloodfeeds, upon the development of Plasmodium berghei in the mosquito vector.Production of a malaria transmission-blocking protein from recombinant yeast.Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.Assessment of Antibodies Induced by Multivalent Transmission-Blocking Malaria Vaccines.Acceptability of a herd immunity-focused, transmission-blocking malaria vaccine in malaria-endemic communities in the Peruvian Amazon: an exploratory study.
P2860
Q21032495-EBCE2BF0-DF31-41D5-837C-4076FF77F7E8Q33591209-82C12B5A-7519-468C-B105-1CFDDEEB5650Q33868257-B5C975D2-CA40-4A9A-BF7C-0EC12426F929Q36236790-93E88229-1334-4B6C-A1A6-2929772D74B4Q36459506-7094567E-FD01-46EB-98AB-6283F2105C31Q36594040-235D1258-4714-40B6-AAEF-FE06F1FA4970Q36795388-4E91C712-D74B-4E17-B372-E2658D380C52Q37025716-1A091C05-1F43-4D50-94B0-94E2D4ABA4D3Q38689928-F429EBE7-E61C-410C-8985-E9238C5536EEQ38917744-EFD6F70B-7652-4B11-8885-804A186A7F83Q39062396-4BE185AD-BE66-4DE9-B48B-215BC2CAE8CAQ41460217-491E5413-AB4B-4130-A17F-CAB2A1CA7DBDQ44169602-1ACEDCD8-3248-444B-BB0B-0F7EFE44268EQ44171631-320FB82D-88DD-49AE-B693-7D00F4D8424FQ44173124-62457D3D-4CA5-496B-A351-58AEBAC32D39Q47711225-92363ED9-0DC4-4195-A84B-1B0BEFFC4CCFQ49730085-F8EF952C-42EC-41C3-A638-6BEC9648B0A2Q55104120-B7F56905-66B3-4200-8D85-F2AFC71DC960
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Malaria transmission-blocking vaccines.
@en
Malaria transmission-blocking vaccines.
@nl
type
label
Malaria transmission-blocking vaccines.
@en
Malaria transmission-blocking vaccines.
@nl
prefLabel
Malaria transmission-blocking vaccines.
@en
Malaria transmission-blocking vaccines.
@nl
P2093
P1476
Malaria transmission-blocking vaccines.
@en
P2093
P304
P356
10.1016/0167-7799(92)90280-9
P577
1992-11-01T00:00:00Z